Termin buchen

Impressum

Angaben gemäß § 5 TMG

lifespin GmbH
Am BioPark 13
93053 Regensburg

Handelsregister: HRB 15934
Registergericht: Regensburg

Vertreten durch:

Dr. Sonja Wiedemann, Dr. Ali Tinazli, Dr. Roland Geyer

Kontakt

Telefon: +49 941/942 898 0
E-mail: info@lifespin.health

Umsatzsteuer-ID

Umsatzsteuer-Identifikationsnummer gemäß § 27 a Umsatzsteuergesetz:
DE 312242690

Verantwortlich für den redaktionellen Inhalt

lifespin GmbH
Am BioPark 13
93053 Regensburg
Deutschland

Streitbeilegung

Wir sind nicht bereit oder verpflichtet, an Streitbeilegungsverfahren vor einer
Verbraucherschlichtungsstelle teilzunehmen.

Webdesign & technische Realisierung

Softloop | Webdesign & WordPress Entwicklung

  • lifespin GmbH | Biopark Regensburg | Am Biopark 13 | 93053 Regensburg
Copyright © 2026 lifespin GmbH. Alle Rechte vorbehalten.
Scroll to Top

Dr. Roland Geyer

COO
10+ years experience in NMR-based metabolomics and diagnostic.
  • Background in medicinal chemistry
  • Built and headed the life sciences department at numares AG
  • Pioneered NMR-based metabolic profiling
  • Successfully implemented 30+ R&D projects for analytical methods, software and systems

Dr. Renate Kirchhöfer

CDO & Co-Founder
20+ years developing NMR-applications and bringing them to regulated markets.
  • Background in Biophysics, computer sciences and NMR. Several patents in this field.
  • Member of the board of lipofit GmbH and numares AG. Establishing internationalization.
  • Co-founded lifespin GmbH in 2017. Setting up company structures.

Dr. Fritz Huber

CEO & Co-Founder
20+ years developing and marketing NMR-based assays—he is a pioneer in this field.
  • Plasma physics, MPI Garching
  • In 2004 he co-founded LipoFIT GmbH, served as its manager, transforming it into numares AG—growing the company into an international operation
  • Co-founded lifespin GmbH in 2017

Dr. Ali Tinazli

CEO, lifespin GmbH
Linkedin Envelope

15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).

  • Built HP’s global healthcare strategy
  • Commercialized first IVD product for billionaire-funded Fluxergy
  • Board member (e.g. Edico Genome acquired by Illumina)